Chemoprophylaxis of malaria in Africa: the spent "magic bullet".
作者信息
Bruce-Chwatt L J
出版信息
Br Med J (Clin Res Ed). 1982 Sep 11;285(6343):674-6. doi: 10.1136/bmj.285.6343.674.
Abstract
摘要
相似文献
1
Chemoprophylaxis of malaria in Africa: the spent "magic bullet".非洲疟疾的化学预防：失效的“神奇子弹”
Br Med J (Clin Res Ed). 1982 Sep 11;285(6343):674-6. doi: 10.1136/bmj.285.6343.674.
2
Practical therapeutics malaria chemoprophylaxis.
East Afr Med J. 1984 Mar;61(3):254-9.
3
4
Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.前往存在对氯喹耐药的恶性疟原虫地区的旅行者对疟疾预防的需求。
MMWR Morb Mortal Wkly Rep. 1986 Jan 17;35(2):21-22, 27.
5
Malaria chemoprophylaxis--which drug?
P N G Med J. 1983 Jun;26(2):127-30.
6
Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.对氯喹和 Fansidar 耐药的恶性疟：对预防的影响
Br Med J (Clin Res Ed). 1983 Oct 1;287(6397):947-8. doi: 10.1136/bmj.287.6397.947.
7
Efficacy of malaria prophylaxis in American and Swiss travelers to Kenya.美国和瑞士前往肯尼亚旅行者的疟疾预防效果。
J Infect Dis. 1987 Jun;155(6):1205-9. doi: 10.1093/infdis/155.6.1205.
8
Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa.
J Infect Dis. 1986 Oct;154(4):689-91. doi: 10.1093/infdis/154.4.689.
9
Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.前往对氯喹耐药的恶性疟原虫流行地区旅行者预防疟疾的修订建议。
MMWR Morb Mortal Wkly Rep. 1985 Apr 12;34(14):185-90, 195.
引用本文的文献
1
Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance.利用疟原虫的进化适应性进行药物发现并抑制耐药性。
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):799-804. doi: 10.1073/pnas.1320886110. Epub 2013 Dec 31.
2
The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.氯喹及其主要代谢产物去乙基氯喹在健康受试者中的单剂量动力学。
Eur J Clin Pharmacol. 1984;26(4):521-30. doi: 10.1007/BF00542151.
3
Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).使用疟涤平（乙胺嘧啶和氨苯砜）预防疟疾期间出现的粒细胞缺乏症。
Postgrad Med J. 1984 Aug;60(706):566-7. doi: 10.1136/pgmj.60.706.566.
4
Malaria prophylaxis for long term visitors.长期访客的疟疾预防
Br Med J (Clin Res Ed). 1983 Nov 12;287(6403):1454-5. doi: 10.1136/bmj.287.6403.1454.
5
Malaria and pregnancy.疟疾与妊娠
Br Med J (Clin Res Ed). 1983 May 7;286(6376):1457-8. doi: 10.1136/bmj.286.6376.1457.
6
Clinical pattern and therapeutic evaluation of falciparum malaria in Tanzanian children.
Indian J Pediatr. 1984 Nov-Dec;51(413):659-60. doi: 10.1007/BF02776382.
7
The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara.撒哈拉以南非洲地区恶性疟原虫耐药性问题。
Bull World Health Organ. 1984;62 Suppl(Suppl):55-62.
8
The impact of malaria chemoprophylaxis in Africa with special reference to Madagascar, Cameroon, and Senegal.疟疾化学预防在非洲的影响，特别提及马达加斯加、喀麦隆和塞内加尔。
Bull World Health Organ. 1984;62 Suppl(Suppl):41-8.
9
Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.双羟萘酸环氯胍和4,4'-二乙酰二氨基二苯砜单独及联合使用时对恒河猴食蟹猴疟原虫感染的抗疟活性。
Antimicrob Agents Chemother. 1984 Nov;26(5):611-42. doi: 10.1128/AAC.26.5.611.
10
Recent trends of chemotherapy and vaccination against malaria: new lamps for old.疟疾化疗与疫苗接种的近期趋势：旧瓶装新酒。
Br Med J (Clin Res Ed). 1985 Oct 19;291(6502):1072-6. doi: 10.1136/bmj.291.6502.1072.
本文引用的文献
1
[Resistance to pyrimethamine in the anti-malarial zone of Thies (Senegal)].
Med Trop (Mars). 1961 Nov-Dec;21:876-8.
2
Advances in chemotherapy.化疗进展
Br Med Bull. 1982 May;38(2):193-9. doi: 10.1093/oxfordjournals.bmb.a071758.
3
Antimalarial drug resistance: an increasing problem.抗疟药耐药性：一个日益严重的问题。
Br Med Bull. 1982 May;38(2):187-92. doi: 10.1093/oxfordjournals.bmb.a071757.
4
Progress in malaria vaccine development.疟疾疫苗研发进展。
Br Med Bull. 1982 May;38(2):161-5. doi: 10.1093/oxfordjournals.bmb.a071753.
5
Genetic variation in malaria parasites.
Br Med Bull. 1982 May;38(2):123-8. doi: 10.1093/oxfordjournals.bmb.a071747.
6
Possible sulfadoxine-pyrimethamine resistance in Plasmodium falciparum malaria from Kenya.肯尼亚恶性疟原虫疟疾中可能存在的磺胺多辛-乙胺嘧啶耐药性。
Trans R Soc Trop Med Hyg. 1982;76(2):281. doi: 10.1016/0035-9203(82)90301-7.
7
Chloroquine sensitivity of Plasmodium falciparum in Ibadan, Nigeria: II. Correlation of in vitro with in vivo sensitivity.尼日利亚伊巴丹恶性疟原虫对氯喹的敏感性：II. 体外敏感性与体内敏感性的相关性
Trans R Soc Trop Med Hyg. 1981;75(5):637-9. doi: 10.1016/0035-9203(81)90138-3.
8
Serum concentrations of chloroquine in a patient with a late recrudescence of Kenyan Plasmodium falciparum malaria.一名肯尼亚恶性疟原虫疟疾晚期复发患者的氯喹血清浓度。
Trans R Soc Trop Med Hyg. 1981;75(3):362-4. doi: 10.1016/0035-9203(81)90093-6.
9
Chloroquine-resistant falciparum malaria in Madagascar and Kenya.马达加斯加和肯尼亚的氯喹耐药恶性疟
Ann Trop Med Parasitol. 1981 Aug;75(4):367-73. doi: 10.1080/00034983.1981.11687454.
10
Malaria 'breakthroughs' and resistance to chloroquine in Africa. Case reports.
S Afr Med J. 1981 Nov 14;60(20):786-8.
Zotero 插件